Transmission of Babesia microti parasites by solid organ transplantation

Emerging Infectious Diseases

Volumn 22, Issue 11, 2016, Pages 1869-1876

  Brennan, Meghan B ^a   Herwaldt, Barbara L ^b   Kazmierczak, James J ^c   Weiss, John W ^a,d   Klein, Christina L ^a   Leith, Catherine P ^a   He, Rong ^a   Oberley, Matthew J ^a   Tonnetti, Laura ^e   Wilkins, Patricia P ^b   Gauthier, Gregory M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Division of Health   (United States)

^d AMERICAN RED CROSS   (United States)

^e HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; BASILIXIMAB; CIPROFLOXACIN; LEVOFLOXACIN; METRONIDAZOLE; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS; BIOLOGICAL MARKER;

ABDOMINAL PAIN; ARTICLE; BABESIA MICROTI; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC NEPHROPATHY; EPIGASTRIC DISCOMFORT; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; LOSS OF APPETITE; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PARASITE TRANSMISSION; PARASITEMIA; PERITONEAL DIALYSIS; PIROPLASMOSIS; POLYMERASE CHAIN REACTION; RRNA GENE; ADULT; AGED; ALLOTRANSPLANTATION; BLOOD TRANSFUSION; DONOR; ERYTHROCYTE; GENETICS; IMMUNOLOGY; MALE; PARASITOLOGY; PATHOLOGY; TIME FACTOR; TRANSMISSION; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; BABESIA MICROTI; BABESIOSIS; BIOMARKERS; BLOOD TRANSFUSION; ERYTHROCYTES; HUMANS; KIDNEY TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; TIME FACTORS; TISSUE DONORS; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 84992065356     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2211.151028     Document Type: Article

References (36)

1. Pfeiffer CD, Kazmierczak JJ, Davis JP. Epidemiologic features of human babesiosis in Wisconsin, 1996-2005. WMJ. 2007;106:191-5.
2. Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366:2397-407. http://dx.doi.org/10.1056/NEJMra1202018
3. Herwaldt BL, Montgomery S, Woodhall D, Bosserman EA; Centers for Disease Control and Prevention (CDC). Babesiosis surveillance—18 states, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:505-9.
4. Kowalski TJ, Jobe DA, Dolan EC, Kessler A, Lovrich SD, Callister SM. The emergence of clinically relevant babesiosis in southwestern Wisconsin. WMJ. 2015;114:152-7.
5. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis. 2001;32:1117-25. http://dx.doi.org/10.1086/319742
6. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134. http://dx.doi.org/10.1086/508667
7. Herwaldt BL, Neitzel DF, Gorlin JB, Jensen KA, Perry EH, Peglow WR, et al. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion. 2002;42:1154-8. http://dx.doi.org/10.1046/j.1537-2995.2002.00189.x
8. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, et al. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion. 2009;49:2557-63. http://dx.doi.org/10.1111/j.1537-2995.2009.02317.x
9. Asad S, Sweeney J, Mermel LA. Transfusion-transmitted babesiosis in Rhode Island. Transfusion. 2009;49:2564-73. http://dx.doi.org/10.1111/j.1537-2995.2009.02380.x
10. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155:509-19. http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00362
11. Leiby DA. Transfusion-transmitted Babesia spp.: bull’s-eye on Babesia microti. Clin Microbiol Rev. 2011;24:14-28. http://dx.doi.org/10.1128/CMR.00022-10
12. Chisholm ES, Ruebush TK II, Sulzer AJ, Healy GR. Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg. 1978;27:14-9.
13. Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thomford JW, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol. 1992;30:2097-103.
14. Torres-Vélez FJ, Nace EK, Won KY, Bartlett J, Eberhard M, Guarner J. Development of an immunohistochemical assay for the detection of babesiosis in formalin-fixed, paraffin-embedded tissue samples. Am J Clin Pathol. 2003;120:833-8. http://dx.doi.org/10.1309/UXPHJRJE2PRUCP1N
15. Belzer FO, D’Alessandro AM, Hoffmann RM, Knechtle SJ, Reed A, Pirsch JD, et al. The use of UW solution in clinical transplantation: a 4-year experience. Ann Surg. 1992;215:579-83, discussion 584-5. http://dx.doi.org/10.1097/00000658-199206000-00004
16. Florescu D, Sordillo PP, Glyptis A, Zlatanic E, Smith B, Polsky B, et al. Splenic infarction in human babesiosis: two cases and discussion. Clin Infect Dis. 2008;46:e8-11. http://dx.doi.org/10.1086/524081
17. El Khoury MY, Gandhi R, Dandache P, Lombardo G, Wormser GP. Non-surgical management of spontaneous splenic rupture due to Babesia microti infection. Ticks Tick Borne Dis. 2011;2:235-8. http://dx.doi.org/10.1016/j.ttbdis.2011.08.001
18. Gupta P, Hurley RW, Helseth PH, Goodman JL, Hammerschmidt DE. Pancytopenia due to hemophagocytic syndrome as the presenting manifestation of babesiosis. Am J Hematol. 1995;50:60-2. http://dx.doi.org/10.1002/ajh.2830500113
19. Slovut DP, Benedetti E, Matas AJ. Babesiosis and hemophagocytic syndrome in an asplenic renal transplant recipient. Transplantation. 1996;62:537-9. http://dx.doi.org/10.1097/00007890-199608270-00018
20. Evenson DA, Perry E, Kloster B, Hurley R, Stroncek DF. Therapeutic apheresis for babesiosis. J Clin Apher. 1998;13:32-6. http://dx.doi.org/10.1002/(SICI)1098-1101(1998)13:1<32::AID-JCA7>3.0.CO;2-A
21. Perdrizet GA, Olson NH, Krause PJ, Banever GT, Spielman A, Cable RG. Babesiosis in a renal transplant recipient acquired through blood transfusion. Transplantation. 2000;70:205-8.
22. Lux JZ, Weiss D, Linden JV, Kessler D, Herwaldt BL, Wong SJ, et al. Transfusion-associated babesiosis after heart transplant. Emerg Infect Dis. 2003;9:116-9. http://dx.doi.org/10.3201/eid0901.020149
23. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al.; West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196-203. http://dx.doi.org/10.1056/NEJMoa022987
24. Stanley E, Ratard R, Staples JE, Royce R, Bower WA, Ellingson KD, et al.; Centers for Disease Control and Prevention (CDC). West Nile virus transmission via organ transplantation and blood transfusion—Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:1263-7.
25. Etkind P, Piesman J, Ruebush TK II, Spielman A, Juranek DD. Methods for detecting Babesia microti infection in wild rodents. J Parasitol. 1980;66:107-10. http://dx.doi.org/10.2307/3280599
26. Vyas JM, Telford SR, Robbins GK. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report. Clin Infect Dis. 2007;45:1588-90. http://dx.doi.org/10.1086/523731
27. Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46:370-6. http://dx.doi.org/10.1086/525852
28. Wormser GP, Prasad A, Neuhaus E, Joshi S, Nowakowski J, Nelson J, et al. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis. 2010;50:381-6. http://dx.doi.org/10.1086/649859
29. Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR III, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000;343:1454-8. http://dx.doi.org/10.1056/NEJM200011163432004
30. Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016;315:1767-77. http://dx.doi.org/10.1001/jama.2016.2884
31. Leiby DA, Johnson ST, Won KY, Nace EK, Slemenda SB, Pieniazek NJ, et al. A longitudinal study of Babesia microti infection in seropositive blood donors. Transfusion. 2014;54:2217-25. http://dx.doi.org/10.1111/trf.12622
32. Leiby DA. Transfusion-associated babesiosis: shouldn’t we be ticked off? Ann Intern Med. 2011;155:556-7. http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00363
33. Gubernot DM, Nakhasi HL, Mied PA, Asher DM, Epstein JS, Kumar S. Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion. 2009;49:2759-71. http://dx.doi.org/10.1111/j.1537-2995.2009.02429.x
34. AABB. Babesiosis. Association Bulletin #14-05. 2014 July 18 [cited 2016 Mar 20]. http://www.aabb.org/programs/publications/bulletins/Documents/ab14-05.pdf.
35. Snyder EL, Stramer SL, Benjamin RJ. The safety of the blood supply—time to raise the bar. N Engl J Med. 2015;372:1882-5. http://dx.doi.org/10.1056/NEJMp1500154
36. Food and Drug Administration. Meeting of the Blood Products Advisory Committee. Strategies for implementation of antibody and nucleic acid-based testing for Babesia microti in blood donors, May 13, 2015 [cited 2016 Mar 20]. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/ucm441228.htm